Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Eur J Intern Med. 2023 Mar;109:73-78. doi: 10.1016/j.ejim.2022.12.024. Epub 2023 Jan 4.
Relative fat mass (RFM) is a novel sex-specific anthropometric equation (based on height and waist measurements) to estimate whole-body fat percentage.
To examine associations of RFM with incident type-2 diabetes (T2D), and to benchmark its performance against body-mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR).
This prospective longitudinal study included data from three Dutch community-based cohorts free of baseline diabetes. First, we examined data from the PREVEND cohort (median age and follow-up duration: 48.0 and 12.5 years, respectively) using Cox regression models. Validation was performed in the Lifelines (median age and follow-up duration: 45.5 and 3.8 years, respectively) and Rotterdam (median age and follow-up duration: 68.0 and 13.9 years, respectively) cohorts.
Among 7961 PREVEND participants, 522 (6.6%) developed T2D. In a multivariable model, all adiposity indices were significantly associated with incident T2D (P<0.001). While 1 SD increase in BMI, WC and WHR were associated with 68%, 77% and 61% increased risk of developing T2D [Hazard ratio (HR): 1.68 (95%CI: 1.57-1.80), HR: 1.77 (95% CI: 1.63-1.92) and HR: 1.61 (95%CI: 1.48-1.75)], an equivalent increase in RFM was associated with 119% increased risk [HR: 2.19 (95%CI: 1.96-2.44)]. RFM was associated with incident T2D across all age groups, with the largest effect size in the youngest (<40 years) age category [HR: 2.90 (95%CI: 2.15-3.92)]. Results were broadly similar in Lifelines (n = 93,870) and Rotterdam (n = 5279) cohorts.
RFM is strongly associated with new-onset T2D and displays the potential to be used in the general practice setting to estimate the risk of future diabetes.
相对脂肪量(RFM)是一种新的性别特异性人体测量方程(基于身高和腰围测量值),用于估计全身脂肪百分比。
研究 RFM 与 2 型糖尿病(T2D)发病的相关性,并将其与体重指数(BMI)、腰围(WC)和腰臀比(WHR)进行比较。
本前瞻性纵向研究纳入了三个荷兰社区为基础的队列中无基线糖尿病的数据。首先,我们使用 Cox 回归模型分析了 PREVEND 队列的数据(中位年龄和随访时间分别为 48.0 岁和 12.5 年)。验证在 Lifelines(中位年龄和随访时间分别为 45.5 岁和 3.8 年)和 Rotterdam(中位年龄和随访时间分别为 68.0 岁和 13.9 年)队列中进行。
在 7961 名 PREVEND 参与者中,有 522 人(6.6%)发生了 T2D。在多变量模型中,所有肥胖指标均与新发 T2D 显著相关(P<0.001)。BMI、WC 和 WHR 每增加 1 个标准差,发生 T2D 的风险分别增加 68%、77%和 61%[风险比(HR):1.68(95%CI:1.57-1.80),HR:1.77(95%CI:1.63-1.92)和 HR:1.61(95%CI:1.48-1.75)],而 RFM 增加 1 个标准差与风险增加 119%相关[HR:2.19(95%CI:1.96-2.44)]。RFM 与所有年龄组的 T2D 发病相关,在年龄最小(<40 岁)的年龄组中,其效应量最大[HR:2.90(95%CI:2.15-3.92)]。在 Lifelines(n=93870)和 Rotterdam(n=5279)队列中也得到了相似的结果。
RFM 与新发 T2D 密切相关,具有在一般实践中用于估计未来糖尿病风险的潜力。